Health Care & Life Sciences » Pharmaceuticals | Enseval Putera Megatrading

Enseval Putera Megatrading | Income Statement

Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
15,623,240
17,011,550
17,476,103
18,936,241
19,669,097
20,604,487
Cost of Goods Sold (COGS) incl. D&A
13,955,922
15,197,024
15,495,386
16,885,794
17,655,694
18,334,749
Gross Income
1,667,318
1,814,526
1,980,717
2,050,447
2,013,402
2,269,739
SG&A Expense
1,038,986
1,151,817
1,261,581
1,349,222
1,368,910
1,429,421
EBIT
619,221
-
693,219
665,204
633,019
805,656
Unusual Expense
169
229
276
882
69
578
Non Operating Income/Expense
286
42,249
17,147
35,237
20,776
14,072
Interest Expense
13,278
15,425
13,038
10,763
9,924
5,391
Pretax Income
622,783
687,780
736,901
745,576
684,758
868,232
Income Tax
158,411
176,661
189,727
189,456
166,922
214,981
Consolidated Net Income
464,372
511,119
547,174
556,121
517,836
653,251
Net Income
464,315
511,065
547,124
556,026
517,671
653,064
Net Income After Extraordinaries
464,315
511,065
547,124
556,026
517,671
653,064
Net Income Available to Common
464,315
511,065
547,124
556,026
517,671
653,064
EPS (Basic)
171.00
189.00
202.00
205.00
191.00
241.10
Basic Shares Outstanding
2,709
2,709
2,709
2,709
2,709
2,709
EPS (Diluted)
171.42
188.68
201.99
205.28
191.12
241.10
Diluted Shares Outstanding
2,709
2,709
2,709
2,709
2,709
2,709
EBITDA
715,200
752,668
822,346
791,999
753,809
932,918
Other Operating Expense
9,110
25,292
25,916
36,022
11,473
34,661
Non-Operating Interest Income
17,295
23,769
39,849
56,780
40,956
54,472
Minority Interest Expense
57
55
50
95
165
187

About Enseval Putera Megatrading

View Profile
Address
Jalan Pulo Lentut No. 10
Jakarta JK 13920
Indonesia
Employees -
Website http://www.enseval.com
Updated 07/08/2019
PT Enseval Putera Megatrading Tbk consumer products, medical equipment, cosmetics, and other trading products. It operates through the following segments: Pharmaceutical, Consumer Products, and Others. The company was founded in October 1973 and is headquartered in Jakarta, Indonesia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.